Skip to content
Clinical Trials – home
Sponsor

Syddansk Universitet (University of Southern Denmark)

Denmark Campusvej 55, 5230 Odense, Denmark

About the sponsor

Research activity is centered on migraine and migraine without aura, with a specific focus on factors that influence headache generation and migraine-like symptoms in affected individuals.

  • Headache provocation
  • Migraine without aura
  • Attack susceptibility

The clinical portfolio reflects sustained interest in the mechanisms underlying migraine symptom expression in adult populations.

About Specializations

Syddansk Universitet (University of Southern Denmark) runs clinical trials in conditions such as Migraine without aura, Migraine, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Migraine without aura

Not yet recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Apremilast
  • Sponsor:Syddansk Universitet (University of Southern Denmark)

Migraine without aura

Not yet recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Gelatin
  • Sponsor:Syddansk Universitet (University of Southern Denmark)

Migraine

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:CILOSTAZOL
  • Sponsor:Syddansk Universitet (University of Southern Denmark)

Migraine without aura

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Glucose Monohydrate
  • Sponsor:Syddansk Universitet (University of Southern Denmark)

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.